IntroductionThe demand for chiral molecules, particularly those with hydrogen as part of the stereogenic center, has increased in recent years, and intensive research has been carried out in both industry and academia to develop efficient methods for synthesizing such compounds [1]. In this context, significant attention has been devoted to the asymmetric hydrogenation of unsaturated compounds, for example, olefins, carbonyls, and imines, which is recognized as one of the most important and convenient routes to the corresponding optically active products [2]. So far, most of the enantioselective reductions rely on biological processes or transition metal catalyzed high-pressure hydrogenations, hydrosilylations, and transfer hydrogenations. Beside their high substrate specificity, the enzymatic processes sometimes suffer from undesired by-products, poor catalyst stability under the operational conditions, substrate and/or product inhibition, and problems with catalyst recovery. Likewise, despite the high reactivity and selectivity exhibited by the organometallic complexes employed in the metal-catalyzed processes, most of these protocols suffer from a limited number of substrates and difficulties with catalyst separation and recycling. Hence, an alternative approach to these chiral compounds would be of great value.
Nature's Reductions: Dehydrogenases as a Role ModelEnzymes are catalysts that evolve in Nature and one of their characteristics is high selectivity. During biochemical transformations, enzymes are assisted by non-proteinogenic molecules called co-factors. For instance, nicotinamide adenine dinucleotide (NADH), one of the essential co-factors in Nature, serves as a hydride source for various biological reductions. The synthesis of the amino acid glutamate by the glutamate dehydrogenase (GDH) catalyzed reductive amination of 2-ketoglutarate represents one example (Equation 22.1). The reaction is reversible Biomimetic Organic Synthesis, First Edition. Edited by Erwan Poupon and Bastien Nay.